Deferred Tax Assets, Valuation Allowance of iBio, Inc. from 30 Jun 2011 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
iBio, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Jun 2011 to 30 Jun 2025.
  • iBio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Jun 2025 was $63,392,000, a 16% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

iBio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $63,392,000 +$8,542,000 +16% 30 Jun 2025 10-K 05 Sep 2025 2025 FY
Q2 2024 $54,850,000 +$5,295,000 +11% 30 Jun 2024 10-K 05 Sep 2025 2025 FY
Q2 2023 $49,555,000 +$12,790,000 +35% 30 Jun 2023 10-K/A 24 Sep 2024 2024 FY
Q2 2022 $36,765,000 +$9,051,000 +33% 30 Jun 2022 10-K 27 Sep 2023 2023 FY
Q2 2021 $27,714,000 +$56,000 +0.2% 30 Jun 2021 10-K 11 Oct 2022 2022 FY
Q2 2020 $27,658,000 +$1,988,000 +7.7% 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q2 2019 $25,670,000 +$4,680,000 +22% 30 Jun 2019 10-K 13 Oct 2020 2020 FY
Q2 2018 $20,990,000 -$4,251,000 -17% 30 Jun 2018 10-K 26 Aug 2019 2019 FY
Q2 2017 $25,241,000 +$6,048,000 +32% 30 Jun 2017 10-K 18 Sep 2018 2018 FY
Q2 2016 $19,193,000 +$270,000 +1.4% 30 Jun 2016 10-K 15 Sep 2017 2017 FY
Q2 2015 $18,923,000 +$2,688,000 +17% 30 Jun 2015 10-K 13 Oct 2016 2016 FY
Q2 2014 $16,235,000 +$1,482,000 +10% 30 Jun 2014 10-K 13 Oct 2015 2015 FY
Q2 2013 $14,753,000 +$2,813,000 +24% 30 Jun 2013 10-K 29 Sep 2014 2014 FY
Q2 2012 $11,940,000 +$20,661,000 30 Jun 2012 10-K/A 04 Oct 2013 2013 FY
Q2 2011 $8,721,000 30 Jun 2011 10-K/A 15 Oct 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.